First Header Logo Second Header Logo

Connection

Karen Haas to Ligands

This is a "connection" page, showing publications Karen Haas has written about Ligands.
Connection Strength

0.201
  1. Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, Tedder TF. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol. 2006 Sep 01; 177(5):3063-73.
    View in: PubMed
    Score: 0.072
  2. Haas KM, Estes DM. The identification and characterization of a ligand for bovine CD5. J Immunol. 2001 Mar 01; 166(5):3158-66.
    View in: PubMed
    Score: 0.049
  3. Haas KM, Estes DM. Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes. Immunology. 2000 Feb; 99(2):272-8.
    View in: PubMed
    Score: 0.045
  4. Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, Kranich J, von Teichman A, Haas KM, Zeller N, Tedder TF, Weis JH, Aguzzi A. Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol. 2007 Nov 01; 179(9):6144-52.
    View in: PubMed
    Score: 0.019
  5. Poe JC, Fujimoto Y, Hasegawa M, Haas KM, Miller AS, Sanford IG, Bock CB, Fujimoto M, Tedder TF. CD22 regulates B lymphocyte function in vivo through both ligand-dependent and ligand-independent mechanisms. Nat Immunol. 2004 Oct; 5(10):1078-87.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.